Elena
Duggento

Associate
Audendum est A. Tibullo

Elena collaborates with professionals from the firm’s Life Sciences team.
She is developing specific skills and deals mainly with regulatory activities in the field of pharmaceutical law, medical devices, nutraceuticals and related scientific research.
She also deals with commercial contracts and opinions on compliance and privacy issues.

Elena joined LCA in November 2021.
Prior to graduation, she did one semester of advance law practice at a boutique firm in Milan, dealing mainly with commercial and corporate law.

Commercial and corporate Life Sciences

You might also be interested in

04.09.2026
LCA advises Impresoft on the sale of 4ward to Lodestar

The deal allows Impresoft to focus on proprietary software, digital transformation and AI, while highlighting 4ward’s industrial f ...

05.08.2026
LCA advises Dokicasa’s shareholders on the sale of the remaining 49% stake t ...

The transaction completes the acquisition process launched in 2024

04.08.2026
LCA on the entry into the share capital of WeRoad by an investment vehicle for whi ...

A secondary investment to support WeRoad’s international growth

03.08.2026
LCA in the acquisition of Hydea by Protos (HIG Capital)

The Firm advised the sellers and management in the group’s external growth transaction

03.08.2026
LCA Studio Legale in the acquisition of Istituto Biochimico Italiano G. Lorenzini ...

A strategic operation in ACS Dobfar Group’s vertical integration path

31.07.2026
LCA for the IPO of Dipietro Group S.p.A.

The team followed the admission to trading on Euronext Growth Milan